![]() |
Is anyone familiar with low dose naltextrone for RX..also Botox in a lumbar block?
Hi all,
I am wondering if anyone is familiar with low dose naltrexone treatment for pain control...Naltrexone is an anti-opiod but apparently in a very low dose it has proven to help with pain.. Does anyone one have experience of having botox included with the mix for a sympathetic lumbar block...(along with the lidocain, etc) in the injection? These two treatments have been discussed with me, but I am not familiar with the added botox and the low dose naltrexone, their effect, side affects, etc. These unknowns are scary...:( Thanks for any information or advice! Hope4thebest xox |
Quote:
As far has Botox in blocks are concerned, I can't recall hearing anything offhand (which desn't mean much) but would be concerned by one issue in particular: what happens if the toxin inadvertantly enters an organ or tissue that you don't want to put into suspended animation for 4 months or so? E.g., liver, heart, etc. Potentially very bad news. Mike |
Bilateral sympathetic block with clonodine????
Hi Mike,
This Thurday, I am having a lumbar block with possibly some clonodine in it ..this will be my first time with clonodine....my 7th lumbar block... they also might want to do a bilateral block (both sides..) yikes.... I've never had a block done on both sides, only my left..... I'm entering into uncharted waters...I need some water wings Hope4thebest |
Good luck --- H4TB --- you are in our thoughts and prayers always. I take clonodine every day for my blood pressure and my RSD, I'm pretty sure its a beta blocker. I never had HBP before all this...in addition clonodine is used for RSD also by some docs. XOXOX Sandy
Quote:
|
Ldn
Hi I have been on LDN for months. When I first came down with the frozen shoulder that started this I was put onit. I started very low. Compounded by McGuff pharmacy in California. It needs to be done by one of the pharmacies listed on the lowdosenaltrexone.org site. I have mine done in a liquid to titrate. It took 50% of my pain away over night and that is when I was systemic pain. All I can say is it has helps calm this. The Lyme disease community and autism/fibro/MS people all use it .
|
naltrexone
Quote:
|
Hi sk8ter and elmodo and NT friends,
Thanks for your info and experiences regardng LDN (lowdosenaltrexone). It has been suggested to me by a university hospital pain center and has been authorized for a 6 week dose by the insurance. I visited a LDN website with several testimonials of success...particularly for fibromyalgia. The dose is very minimal from the dose of its intended use as an anti-opioid. Sk8ter! I am encouraged to read that you have experiened a 50 % reduction in pain! I am wondering if there are any side effects associated with it, or any change in mental processes..I have a very detailed job and I have to be able to think straight!!! I'm curious as to how yur doc got the info and the validation to use this med!! It would help bolster my confidence to use it! I am so glad you are getting relief..is your dose more than 4.5 ? I hope you continue to have relief! Elmodo! First, I am so sorry that your daughter was diagnosed with jRSD during her pregnancy...Pregnancy should be a time of joy and anticipation and my heart goes out to her in having to deal with this diagnosis. I hope you share Sk8ter's positive outcome of using LDN with her, and she might want to visit the website that gives thorough info...if you google low dose naltrexone you can access the website. It has been recommended to me by a university hospital in California by pain management specialists.. I am sorry your daughter was discouraged and convinced to halt the medication when she was actually getting relief..I hope she is able to give it another try. It is given by mainstream pain specialists....not just alternative wellness doctors... I, too, am fearful of meds, but I'm getting to the point where I am considering the LDN, at least for just 6 weeks... I don't know what DMSO IV's are..I hope you can share some info about this treatment. I had my 7th lumbar block today with clonodine in the mix to make the marcane (sp) last longer....it did warm my leg up a bit, but thus far..(7 hours later) I really don't have any relief.....and my back hurts like h--- :eek: I think so much of my pain is from entrapped or damaged nerves in my foot. Sandy and Mike, as always thanks for your support, information and friendship......I thought of the board while I was getting the block today (without sedation) it helped me through...:hug: hope4thebest xoxox |
Ldn
Please make sure you use only one of the pharmacy on the LDN site. You need to start low ..like 1mg and go uo .5 every 2 weeks or so. Sleep can be affected for a few weeks. I did not have this and actually slept better. Do Not go over 4.5mg as this can then have a reverse affect. Everyone's body is different . I am very sensitive and can only take 2 mg. If you have low blood pressure it can drop it to but will level out for most. I hope this helps. Try to find a dr that has used this. I think on the LDN there is a dr referral if not call one of the pharmacy on the list and they can tell you one near you.
God Bless:winky: |
Article on use of botox in blocks
I know this is late - but I received this information from a news service that I subscribe to:
Sympathetic Blockade with Botulinum Toxin - A Promising New Treatment for Reflex Sympathetic Dystrophy Reflex sympathetic dystrophy (RSD), also known as complex regional pain syndrome (CRPS) Type I, is a complex, chronic, pain syndrome that can affect any part of the body, however, it occurs most frequently in the extremities - hands, feet, arms, legs, shoulders or knees. It has been recognized by many clinicians as a distinct clinical condition for over 100 years and has been known by various names including algodystrophy, Sudeck's atrophy, causalgia, and sympathetically maintained pain. Reflex sympathetic dystrophy is characterized by: Severe, chronic, pain - often described as stinging or burning Sensory abnormalities - allodynia (extreme sensitivity to touch) Motor changes such as tremor or stiffness Edema (tissue swelling) and hyperhydrosis (excessive sweating) Progressive changes to skin, hair, nails, muscle, and bone Increasing dysfunction of the affected limb Sympathetic nerve block injections have long been used for the treatment of RSD, however, pain relief is achieved for only a short period of time for many patients. Surgical or chemical sympathectomy is also a widely used treatment for RSD but, in general, also has not been found to provide effective, long-term pain relief for many people who suffer with RSD. Clearly, there is an urgent need to develop more effective, long-lasting pain relief treatment options for patients with RSD. In an article published in 2009 in the Annals of Neurology (Volume 65; pp. 348-351), investigators from the Stanford University School of Medicine in Stanford, California, reported on the results of a pilot, randomized, controlled study in which they evaluated the efficacy of sympathetic nerve block injections with botulinum toxin type A (BTA) for the treatment of RSD. Because this was intended to be a pilot (preliminary) study, only 9 patients were recruited for inclusion in the trial. Seven (7) of these 9 patients eventually completed the trial and served as the basis for the data-set analysis of the study. All 7 patients had sympathetically-maintained pain of the lower extremity cause by CRPS type I (RSD). All of these patients had previously failed to achieve adequate pain relief with analgesic medications that are often prescribed for patients with RSD (such as anticonvulsants and tricyclic antidepressants). At the initation of the study protocol, all patients received a standard lumbar sympathetic nerve block injection of 0.5% bupivacaine (a local anesthetic). If, after 30 days of receiving a standard lumbar sympathetic block, the intensity of pain had returned to "baseline" levels (same level of pain as before receiving the standard injection of 0.5% bupivacaine), the patients received a second lumbar sympathetic block injection of 0.5% bupivacaine plus 75 units of botulinum toxin type A. (BTA). The preliminary end-point measured by the study was the time to return to baseline pain intensity, which was then considered as "analgesic failure". Patients were required to keep daily records of pain intensity using a visual analog pain intensity scale, starting at 7-days before the first injection and continuing daily for 30 days, thereafter. The results of this pilot study demonstrated that the duration of pain relief was extended significantly when botulinum toxin type A (BTA) was added to the standard 0.5% bupivacaine lumbar sympathetic block. The mean time of pain relief with the standard sympathetic block of 5% bupivacaine alone was less than 10 days. In contrast, the addition of BTA to the standard sympathetic block extended the mean time of pain relief to 71 days (10 weeks). The only adverse event recorded among the patients who received the BTA-supplemented sympathetic block injection was nausea and vomiting in one patient which resolved spontaneously after 2 days. In conclusion, this pilot study offers preliminary evidence that lumbar sympathetic blockade with a combination of a local anesthetic (0.5% bupivacaine) and botulinum toxin type A (BTA) may be a reasonable treatment option for the management of sympthetically-maintained pain in patients with CRPS type I who have failed to respond to other treatments. The authors noted, however, that since only a small number of patient were included in this pilot study, nevertheless, the promising results obtained warrant further evaluation of BTA-supplemented sympathetic blockade in a larger cohort of patients with RSD. Quote:
|
the article follows . . .
Sandy,
Thank you! That was obviously news to me. :o (Worse yet if I saw and forgot it.) So running the names of the priciple investigators on the next study (see below), here it is: Carroll I, Clark JD, Mackey S., Sympathetic block with botulinum toxin to treat complex regional pain syndrome, Ann Neurol. 2009 Mar;65(3):348-51 FREE FULL TEXT at http://www.ncbi.nlm.nih.gov/pmc/arti...ihms140157.pdf Abstracthttp://www.ncbi.nlm.nih.gov/pubmed/19334078 And if you go on the RSDSA site, one of the first things you'll see on the homepage is that enrollment in the follow up study is now open ! http://www.rsds.org/3/research/Stanford_BotoxStudy.html Drs. Ian Carroll and Sean Mackey are apparently the lead investigators. You will see the same form in the STANFORD SYSTEMS NEUROSCIENCE & PAIN LABORATORY (SNAPL) website, at http://snapl.stanford.edu/botox/ along with its "secure screening questionnaire" for the new study https://med.stanford.edu/survey/botoxsn/ Note one thing in both the news release and the abstract, it says that the addition of BTA to the standard sympathetic block extented the mean time of post-block pain relief from "less than 10 days . . . . to 71 days (10 weeks)," thereby implying that a good number of the controls were still in the acute phase, otherwise they would be highly unlikely to get anything approaching 10 days of relief from a standard block. When going through the article, it is a little cryptic about the range of time folks had CRPS prior to entering the study: "All patients . . . had: (1) spontaneous pain rating greater than 6 of 10; (2) duration of pain at least 6 months; . . . ." That said, I note that "How long have you had pain in this area?" is a field in the new "screening form." [Translation: if length of affliction is not explicitly noted in the report of the first study, then it really must be in the next, especially if they are using any particular duration of pain over six months as a screening criteria.] Among the many possibilities this work raises, is the following: If, in at least the acute phase, an LSB+ will buy 10 weeks of relief, how long could you keep it going by scheduling the procedure every two months? The notice of the new study doesn't suggest that it's going in that direction (intermixing the test juice with the control in apparently all subjects) and the consent form spells it out: all subjects will receive two blocks four week apart, one a basic block and the other with BTA, double-blinding the order in which they are delivered. http://snapl.stanford.edu/botox/Consent_11-17-09.doc But perhaps later on. Then again, the article notes something that suggests this is not for the squeemish: Adverse Events—One [of ten] patient experienced significant nausea and emesis that started 5 hours after her BTA injection and lasted 2 days; it resolved spontaneously.Mike |
All times are GMT -5. The time now is 08:52 PM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.